BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 7519411)

  • 1. Somnogenic effects of rabbit and recombinant human interferons in rabbits.
    Kimura M; Majde JA; Toth LA; Opp MR; Krueger JM
    Am J Physiol; 1994 Jul; 267(1 Pt 2):R53-61. PubMed ID: 7519411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses.
    Buckwold VE; Wei J; Huang Z; Huang C; Nalca A; Wells J; Russell J; Collins B; Ptak R; Lang W; Scribner C; Blanchett D; Alessi T; Langecker P
    Antiviral Res; 2007 Feb; 73(2):118-25. PubMed ID: 16987555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay.
    Schiller JH; Willson JK; Bittner G; Wolberg WH; Hawkins MJ; Borden EC
    J Interferon Res; 1986 Dec; 6(6):615-25. PubMed ID: 2437222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 is pyrogenic but not somnogenic.
    Opp M; Obal F; Cady AB; Johannsen L; Krueger JM
    Physiol Behav; 1989 May; 45(5):1069-72. PubMed ID: 2476835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of CHO cell-derived rhIFN-ω-Fc with improved pharmacokinetics.
    Li J; Li B; Zhang J; Hou L; Yu C; Fu L; Song X; Yu T; Zhang J; Ren J; Xu C; Chen W
    Antiviral Res; 2011 Mar; 89(3):199-203. PubMed ID: 21277904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of human interferons on the immortalization of human, but not rabbit, T lymphocytes by human T-lymphotropic virus type-I (HTLV-I).
    Oka T; Iwata J; Furihata M; Sonobe H; Miyoshi I; Ohtsuki Y
    Int J Cancer; 1992 Jul; 51(6):915-20. PubMed ID: 1639539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
    Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
    J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative anti-herpes simplex virus effects of human interferons.
    Taylor JL; Little SD; O'Brien WJ
    J Interferon Cytokine Res; 1998 Mar; 18(3):159-65. PubMed ID: 9555977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferons in enteroviral heart disease: modulation of cytokine expression and antiviral activity.
    Heim A; Weiss S
    Med Microbiol Immunol; 2004 May; 193(2-3):149-54. PubMed ID: 13680216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferons in the pathogenesis and treatment of canine diseases.
    Klotz D; Baumgärtner W; Gerhauser I
    Vet Immunol Immunopathol; 2017 Sep; 191():80-93. PubMed ID: 28895871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human trophoblast interferons: production and possible roles in early pregnancy.
    Aboagye-Mathiesen G; Tóth FD; Zdravkovic M; Ebbesen P
    Early Pregnancy; 1995 Mar; 1(1):41-53. PubMed ID: 9363235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis.
    Kato A; Ohnishi Y; Kohase M; Saito S; Tashiro M; Nagai Y
    J Virol; 2001 Apr; 75(8):3802-10. PubMed ID: 11264369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-beta induces sleep, fever, and anorexia.
    Kapás L; Krueger JM
    Am J Physiol; 1992 Sep; 263(3 Pt 2):R703-7. PubMed ID: 1415661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep.
    Shoham S; Davenne D; Cady AB; Dinarello CA; Krueger JM
    Am J Physiol; 1987 Jul; 253(1 Pt 2):R142-9. PubMed ID: 3496800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyriboinosinic:polyribocytidylic acid enhances rabbit slow-wave sleep.
    Krueger JM; Majde JA; Blatteis CM; Endsley J; Ahokas RA; Cady AB
    Am J Physiol; 1988 Nov; 255(5 Pt 2):R748-55. PubMed ID: 3189588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus.
    Subramanian GM; Moore PA; Gowen BB; Olsen AL; Barnard DL; Paragas J; Hogan RJ; Sidwell RW
    Chemotherapy; 2008; 54(3):176-80. PubMed ID: 18560223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the in vitro host range of recombinant met-interferon-con1, interferon-alpha 2b, and interferon-beta [corrected].
    Hu CJ; Ozes ON; Klein SB; Blatt LM; Taylor MW
    J Interferon Cytokine Res; 1995 Mar; 15(3):231-4. PubMed ID: 7584668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell activity against cultured melanoma cells: a dye-reduction technique with studies on augmented activity by interferon subtypes.
    Losinno C; Wines BD; Johns TG; Mackay IR
    Nat Immun; 1992; 11(4):215-24. PubMed ID: 1384830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I interferons inhibit interleukin-10 production in activated human monocytes and stimulate IL-10 in T cells: implications for Th1-mediated diseases.
    Feng X; Yau D; Holbrook C; Reder AT
    J Interferon Cytokine Res; 2002 Mar; 22(3):311-9. PubMed ID: 12034038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 1 alpha and an interleukin 1 beta fragment are somnogenic.
    Obal F; Opp M; Cady AB; Johannsen L; Postlethwaite AE; Poppleton HM; Seyer JM; Krueger JM
    Am J Physiol; 1990 Sep; 259(3 Pt 2):R439-46. PubMed ID: 2396703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.